FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Rizzieri

Research Profile

Procedures

Concepts & Ideas

Disorders

Physiology

Graft Survival

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Mehdi Hamadani; Parameswaran N Hari; Jack W Hsu; David J Inwards; Rammurti T Kamble; Anderas Klein; Ginna G Laport; Dipnarine Maharaj; David G Maloney; David I Marks; Silvia Montoto; David A Rizzieri; Wael Saber; Bipin N Savani; Harry C Schouten; Edmund K Waller; Baldeep Wirk; Kwang Woo Ahn; Mitchell S Cairo; Jeanette Carreras; Timothy S Fenske; Robert Peter Gale; John Gibson; Gregory A Hale; Hillard M Lazarus
Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III Follicular Lymphoma.
Mehdi Hamadani; Parameswaran N Hari; Jack W Hsu; David J Inwards; Rammurti T Kamble; Anderas Klein; Kwang Woo Ahn; Mitchell S Cairo; Jeanette Carreras; Timothy S Fenske; Robert Peter Gale; John Gibson; Gregory A Hale; Dipnarine Maharaj; David I Marks; David A Rizzieri; Wael Saber; Bipin N Savani; Harry C Schouten; Edmund K Waller; Baldeep Wirk; Hillard M Lazarus
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.
Manabu Kurokawa; Andrew N Macintyre; Jeffrey C Rathmell; Tannishtha Reya; David A Rizzieri; Chih-Sheng Yang; Chen Zhao; Michael W Deininger; Takahiro Ito; Sally Kornbluth
Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Rizzieri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Mehdi Hamadani; Parameswaran N Hari; Jack W Hsu; David J Inwards; Rammurti T Kamble; Anderas Klein; Ginna G Laport; Dipnarine Maharaj; David G Maloney; David I Marks; Silvia Montoto; David A Rizzieri; Wael Saber; Bipin N Savani; Harry C Schouten; Edmund K Waller; Baldeep Wirk; Kwang Woo Ahn; Mitchell S Cairo; Jeanette Carreras; Timothy S Fenske; Robert Peter Gale; John Gibson; Gregory A Hale; Hillard M Lazarus
Impact of Pretransplantation Conditioning Regimens on Outcomes of Allogeneic Transplantation for Chemotherapy-Unresponsive Diffuse Large B Cell Lymphoma and Grade III Follicular Lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(5):746-53.
2013: Mehdi Hamadani; Parameswaran N Hari; Jack W Hsu; David J Inwards; Rammurti T Kamble; Anderas Klein; Kwang Woo Ahn; Mitchell S Cairo; Jeanette Carreras; Timothy S Fenske; Robert Peter Gale; John Gibson; Gregory A Hale; Dipnarine Maharaj; David I Marks; David A Rizzieri; Wael Saber; Bipin N Savani; Harry C Schouten; Edmund K Waller; Baldeep Wirk; Hillard M Lazarus
Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(4):625-31.
2013: Manabu Kurokawa; Andrew N Macintyre; Jeffrey C Rathmell; Tannishtha Reya; David A Rizzieri; Chih-Sheng Yang; Chen Zhao; Michael W Deininger; Takahiro Ito; Sally Kornbluth
Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(6):2300-5.
2013: Leena V Maramattom; David I Marks; Richard T Maziarz; Silvia Montoto; David A Rizzieri; Baldeep Wirk; William Arcese; Linda J Burns; Mitchell S Cairo; Jeanette Carreras; Luciano J Costa; Timothy S Fenske; Cesar O Freytes; Robert Peter Gale; Thomas G Gross; gregory alan hale; Mehdi Hamadani; Parameswaran Hari; Leona A Holmberg; Jack W Hsu; David J Inwards; Hillard M Lazarus; Michael Lill; David G Maloney; James L Gajewski
Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(2):173-9.
2013: Tod A Morris; David A Rizzieri; Carlos M DeCastro; Louis F Diehl; Jon P Gockerman; Anand S Lagoo; Zhiguo Li; Joseph O Moore; Arati V Rao
Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia.
Leukemia research 2013;37(1):28-31.
2012: David A Rizzieri
MDS: unraveling the mystery.
Blood 2012;120(25):4906-8.
2012: Ivan Spasojevic; Keith M Sullivan; Nelson J Chao; John P Chute; Ligia R S da Costa; Cristina Gasparetto; Mitchell E Horwitz; Gwynn D Long; Ashley Morris; David A Rizzieri
Mini test dose of intravenous busulfan (busulfex(®)) in allogeneic non-myeloablative stem cell transplantation, followed by liquid chromatography tandem-mass spectrometry.
Cancer investigation 2012;30(9):679-82.
2012: Junya Kanda; John Andrew Livingston; Gwynn D Long; Jacalyn McPherson; Ashley Morris; Donna Niedzwiecki; David A Rizzieri; Gregory D Sempowski; Keith M Sullivan; Paul Szabolcs; Gloria Broadwater; Nelson J Chao; Lun-Wei Chiou; John P Chute; Cristina Gasparetto; Jeffrey Hale; Mitchell E Horwitz
Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(11):1664-1676.e1.
2012: Susan O'Brien; Farhad Ravandi; David A Rizzieri; Mikkael A Sekeres; Karin Staudacher; Adriano Venditti; Norbert Vey; Trygve Bergeland; Donald A Berry; Mike Dennis; Tove Flem Jacobsen; Utz O Krug; Francis J Giles
Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia.
British journal of haematology 2012;158(5):581-8.
2012: M E Horwitz; Gwynn D Long; C McDonald; A Morris; David A Rizzieri; K M Sullivan; John P Chute; Cristina Gasparetto; Nelson J Chao
Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration.
Bone marrow transplantation 2012;47(8):1051-5.
2012: Stefan Faderl; Siddhartha Ganguly; Stuart Goldberg; Jochen Greiner; Parameswaran Hari; Dirk Huebner; Madan Jagasia; Tibor Kovacsovics; Michael Maris; Farhad Ravandi; Christian Recher; David A Rizzieri; Gary Schiller; Karen Seiter; Robert Stuart; Michael Vasconcelles; Norbert Vey; Eunice S Wang; Meir Wetzler; David Avigan; Robert Collins; Michael Craig; Hagop M Kantarjian
Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(20):2492-9.
2012: gregory alan hale; Brian J Bolwell; Linda J Burns; Cesar O Freytes; Robert Peter Gale; John Gibson; Jack W Hsu; David J Inwards; Luis Isola; Ginna G Laport; Hillard M Lazarus; Jennifer Le-Rademacher; Silvia Montoto; David A Rizzieri; Smriti Shrestha; Shimon Slavin; Parameswaran N Hari
Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(7):1036-1043.e1.
2012: D-F Chen; John P Chute; A Clark; A DeOliveira; Cristina Gasparetto; M E Horwitz; Gwynn D Long; V K Prasad; Nancy L Reinsmoen; Gloria Broadwater; Nelson J Chao; K M Sullivan; Y Yang; David A Rizzieri
Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors.
Bone marrow transplantation 2012;47(6):817-23.
2012: J Kanda; Z Li; Gwynn D Long; A Morris; Nelson J Chao; John P Chute; Cristina Gasparetto; T Hennig; M E Horwitz; K M Sullivan; David A Rizzieri
Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 2012;47(5):700-5.
2012: David A Rizzieri; Katherine Walsh
Chemoimmunotherapy's potential to impact paroxysmal nocturnal hemoglobinuria.
Clinical advances in hematology & oncology : H&O 2012;10(2):136-7.
2012: Mark C Lanasa; Zhiguo Li; Karen M B Matta; Joseph O Moore; Catherine W Rehder; J Brice Weinberg; Harry Cook; Michael Datto; F Joseph Daugherty; Patricia H Davis; Carlos M DeCastro; Louis F Diehl; Daphne R Friedman; Jon P Gockerman; David A Rizzieri
Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia.
Leukemia & lymphoma 2012;53(2):218-24.
2011: Sherif S Farag; Stephen L George; Luis Isola; Richard A Larson; Hillard M Lazarus; Mark R Litzow; Kati Maharry; Guido Marcucci; David I Marks; Krzysztof Mrózek; Waleska S Pérez; Olle Ringdén; David A Rizzieri; Robert Soiffer; Martin S Tallman; Daniel J Weisdorf; Mei-Jie Zhang; Maria R Baer; Clara D Bloomfield; Donald W Bunjes; Mitchell S Cairo; Edward Copelan; Corey Cutler; John DiPersio
Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(12):1796-803.
2011: Chris R Kelsey; David A Rizzieri; Beverly Steffey; Nelson J Chao; Junzo P Chino; Oana Craciunescu; Rodney J Folz; Mitchell E Horwitz; Lawrence B Marks
Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors.
International journal of radiation oncology, biology, physics 2011;81(3):812-8.
2011: Junya Kanda; David A Rizzieri; Cristina Gasparetto; Gwynn D Long; John P Chute; Keith M Sullivan; Ashley Morris; Clayton A Smith; Donna E Hogge; Janet Nitta; Kevin Song; Donna Niedzwiecki; Nelson J Chao; Mitchell E Horwitz
Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(6):867-74.
2011: Anjali Advani; Sarah Gibson; Elizabeth Douglas; Julia Diacovo; Paul Elson; Matt Kalaycio; Edward A Copelan; Mikkael A Sekeres; Ronald Sobecks; Shawnda Sungren; Anand S Lagoo; David A Rizzieri; Eric D Hsi
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL).
British journal of haematology 2011;153(4):504-7.
2011: Junya Kanda; Richard D Lopez; David A Rizzieri
Alemtuzumab for the prevention and treatment of graft-versus-host disease.
International journal of hematology 2011;93(5):586-93.
2011: Oana I Craciunescu; Beverly A Steffey; Chris R Kelsey; Nicole Larrier; Cathy J Paarz-Largay; Robert G Prosnitz; Nelson Chao; John P Chute; Cristina Gasparetto; Mitchell Horwitz; Gwynn Long; David A Rizzieri; Keith M Sullivan
Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial.
International journal of radiation oncology, biology, physics 2011;79(4):1248-55.
2011: David A Rizzieri; Christopher Crout; Robert Storms; Jared Golob; Gwynn D Long; Cristina Gasparetto; Keith M Sullivan; Mitchell Horwitz; John P Chute; Anand S Lagoo; Ashley Morris; Anne Beaven; Yiping Yang; Bercedis Peterson; Zhiguo Li; Nelson J Chao
Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors.
Cancer investigation 2011;29(1):56-61.
2010: Anjali Advani; Mazyar Shadman; Francis Ali-Osman; Andrew Barker; Lisa Rybicki; Matt Kalaycio; Mikkael A Sekeres; Carlos M de Castro; Louis F Diehl; Joseph O Moore; Anne Beaven; Ed Copelan; Ronald Sobecks; Parisa Talea; David A Rizzieri
A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse.
Clinical lymphoma, myeloma & leukemia 2010;10(6):473-6.
2010: Vikas Gupta; Martin S Tallman; Wensheng He; Brent R Logan; Edward Copelan; Robert Peter Gale; Hanna J Khoury; Thomas Klumpp; John Koreth; Hillard M Lazarus; David I Marks; Rodrigo Martino; David A Rizzieri; Jacob M Rowe; Mitchell Sabloff; Edmond WALLER; John F DiPersio; Donald W Bunjes; Daniel J Weisdorf
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.
Blood 2010;116(11):1839-48.
2010: Junya Kanda; Nelson J Chao; David A Rizzieri
Haploidentical transplantation for leukemia.
Current oncology reports 2010;12(5):292-301.
2010: Michel Duval; John P Klein; Wensheng He; Jean-Yves Cahn; Mitchell S Cairo; Bruce M Camitta; Rammurti Kamble; Edward A Copelan; Marcos de Lima; Vikas Gupta; Armand Keating; Hillard M Lazarus; Mark R Litzow; David I Marks; Richard T Maziarz; David A Rizzieri; Gary Schiller; Kirk R Schultz; Martin S Tallman; Daniel Weisdorf
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(23):3730-8.
2010: David A Rizzieri; Robert Storms; Dong-Feng Chen; Gwynn Long; Yiping Yang; Daniel A Nikcevich; Cristina Gasparetto; Mitchell Horwitz; John Chute; Keith Sullivan; Therese Hennig; Debashish Misra; Christine Apple; Megan Baker; Ashley Morris; Patrick G Green; Vic Hasselblad; Nelson J Chao
Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(8):1107-14.
2010: David I Marks; Tao Wang; Waleska S Pérez; Joseph H Antin; Edward A Copelan; Robert Peter Gale; Biju George; Vikas Gupta; Joerg Halter; H Jean Khoury; Thomas R Klumpp; Hillard M Lazarus; Victor A Lewis; Philip McCarthy; David A Rizzieri; Mitchell Sabloff; Jeff Szer; Martin S Tallman; Daniel J Weisdorf
The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission.
Blood 2010;116(3):366-74.
2010: Christopher A Crout; Liang-Piu Koh; Jon P Gockerman; Joseph O Moore; Carlos M DeCastro; Gwynn D Long; Louis Diehl; Cristina Gasparetto; Donna Niedzwiecki; Jon Edwards; Leonard R Prosnitz; Mitchell Horwitz; Jon Chute; Ashley Morris; Patricia Davis; Anne Beaven; Nelson J Chao; Francis Ali-Osman; David A Rizzieri
Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy.
Cancer investigation 2010;28(6):654-60.
2010: David A Rizzieri; Samantha LoRusso; William Tse; Khuda Khan; Anjali Advani; Joseph Moore; Verena Karsten; Ann Cahill; Stanton L Gerson
Phase I study of temozolomide and laromustine (VNP40101M) in patients with relapsed or refractory leukemia.
Clinical lymphoma, myeloma & leukemia 2010;10(3):211-6.
2010: Cristina Gasparetto; Jon P Gockerman; Louis F Diehl; Carlos M de Castro; Joseph O Moore; Gwynn D Long; Mitchell E Horwitz; George Keogh; John P Chute; Keith M Sullivan; Rachel Neuwirth; Patricia H Davis; Linda M Sutton; Russell D Anderson; Nelson J Chao; David A Rizzieri
"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(1):70-7.
2009: Arati V Rao; Peter J M Valk; Klaus Metzeler; Chaitanya R Acharya; Sascha A Tuchman; Marvaretta M Stevenson; David A Rizzieri; Ruud Delwel; Christian Buske; Stefan K Bohlander; Anil Potti; Bob Löwenberg
Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(33):5580-6.
2009: David A Rizzieri; Jenny A O'Brien; Gloria Broadwater; Carlos M DeCastro; Prakash Dev; Louis Diehl; Anne Beaven; Anand S Lagoo; Jon P Gockerman; Nelson J Chao; Joseph O Moore
Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia.
Cancer 2009;115(13):2922-9.
2009: H Miles Prince; Dirk Hönemann; Andrew Spencer; David A Rizzieri; Edward A Stadtmauer; Andrew W Roberts; Nizar Bahlis; Guido Tricot; Bill Bell; Douglas J Demarini; A Benjamin Suttle; Katherine L Baker; Lini N Pandite
Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).
Blood 2009;113(19):4819-20.
2009: Jenny Zhang; Dereje D Jima; Cassandra Jacobs; Randy Fischer; Eva Gottwein; Grace Huang; Patricia L Lugar; Anand S Lagoo; David A Rizzieri; Daphne R Friedman; J Brice Weinberg; Peter E Lipsky; Sandeep S Dave
Patterns of microRNA expression characterize stages of human B-cell differentiation.
Blood 2009;113(19):4586-94.
2009: Thomas C Shea; Anne W Beaven; Dominic T Moore; Jonathan S Serody; Don A Gabriel; Nelson Chao; Jon P Gockerman; Reynaldo A Garcia; David A Rizzieri
Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival.
Leukemia & lymphoma 2009;50(5):741-8.
2008: Arati V Rao; Islam R Younis; Gregory J Sand; Ivan Spasojevic; David J Adams; Carlos M DeCastro; Jon P Gockerman; Bercedis L Peterson; William P Petros; Joseph O Moore; David A Rizzieri
Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia.
Leukemia & lymphoma 2008;49(8):1523-9.
2008: David A Rizzieri; Eric Feldman; John F Dipersio; Nashat Gabrail; Wendy Stock; Roger Strair; Victor M Rivera; Maher Albitar; Camille L Bedrosian; Francis Giles
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2756-62.
2008: Mitchell E Horwitz; Ashley Morris; Cristina Gasparetto; Keith Sullivan; Gwynn Long; John P Chute; David A Rizzieri; Jackie McPherson; Nelson Chao
Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(5):591-4.
2008: David J Adams; Marit L Sandvold; Finn Myhren; Tove F Jacobsen; Francis Giles; David A Rizzieri
Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.
Leukemia & lymphoma 2008;49(4):786-97.
2008: Arthur Frankel; Jen-Sing Liu; David A Rizzieri; Donna E Hogge
Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia.
Leukemia & lymphoma 2008;49(3):543-53.
2008: Sonali M Smith; DL Grinblatt; Jeffrey L Johnson; Donna Niedzwiecki; David A Rizzieri; Nancy L Bartlett; Bruce D Cheson
Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B.
British journal of haematology 2008;140(3):313-9.
2008: B J Byrne; Mitchell Horwitz; Gwynn D Long; Cristina Gasparetto; Keith M Sullivan; John P Chute; Nelson J Chao; David A Rizzieri
Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection.
Bone marrow transplantation 2008;41(1):39-43.
2007: Mitchell E Horwitz; Ivan Spasojevic; Ashley Morris; Marilyn J Telen; James Essell; Cristina Gasparetto; Keith Sullivan; Gwynn Long; John P Chute; Nelson Chao; David A Rizzieri
Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1422-6.
2007: J Brice Weinberg; Alicia D Volkheimer; Youwei Chen; Bethany E Beasley; Ning Jiang; Mark C Lanasa; Daphne Friedman; Gina Vaccaro; Catherine W Rehder; Carlos M DeCastro; David A Rizzieri; Louis F Diehl; Jon P Gockerman; Joseph O Moore; Barbara K Goodman; Marc C Levesque
Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.
American journal of hematology 2007;82(12):1063-70.
2007: Liang-Piu Koh; David A Rizzieri; Nelson J Chao
Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(11):1249-67.
2007: David A Rizzieri; Liang-Piu Koh; Gwynn D Long; Cristina Gasparetto; Keith M Sullivan; Mitchell Horwitz; John P Chute; Clayton Smith; Jerald Z Gong; Anand S Lagoo; Donna Niedzwiecki; Jeannette M Dowell; Barbara Waters-Pick; CongXiao Liu; Dawn Marshall; James J Vredenburgh; Jon P Gockerman; Carlos M DeCastro; Joseph Moore; Nelson J Chao
Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(6):690-7.
2007: Francis Giles; David A Rizzieri; Judith E Karp; Norbert Vey; Farhad Ravandi; Stefan Faderl; Khuda Dad Khan; Gregor Verhoef; Pierre W Wijermans; Anjali Advani; Gail J Roboz; Andrew Lamb; Syed Fazl Ali Bilgrami; Augustin Ferrant; S M G J Daenen; Verena Karsten; Ann Cahill; Maher Albitar; Ghulam Mufti; Susan O'Brien
Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):25-31.
2006: Anand S Lagoo; Jerald Z Gong; Timothy T Stenzel; Barbara K Goodman; Patrick J Buckley; Nelson J Chao; Cristina Gasparetto; Gwynn D Long; David A Rizzieri
Morphologic examination of sequential bone marrow biopsies after nonmyeloablative stem cell transplantation complements molecular studies of donor engraftment.
Archives of pathology & laboratory medicine 2006;130(10):1479-88.
2006: Gary J Schiller; James Slack; John D Hainsworth; James Mason; Mansoor Saleh; David A Rizzieri; Dan Douer; Alan F List
Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2456-64.
2006: James J Vredenburgh; David Coniglio; Gloria Broadwater; Roy B Jones; Maureen Ross; Elizabeth J Shpall; Atif Hussein; David A Rizzieri; Lawrence Marks; Colleen Gilbert; Mary Lou Affronti; Sarah Moore; Carolyn McDonald; William P Petros; William P Peters
Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemotherapy alone.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(2):195-203.
2005: Jens Dannull; Zhen Su; David A Rizzieri; Benjamin K Yang; Doris Coleman; Donna Yancey; Aijing Zhang; Philipp Dahm; Nelson Chao; Eli Gilboa; Zhen Su
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells.
The Journal of clinical investigation 2005;115(12):3623-33.
2005: David A Rizzieri; Martha Wadleigh; Carol J Wikstrand; Karen P Mann; Filiz Sen; Bercedis L Peterson; Donna Niedzwiecki; Alan D Proia; Darell D Bigner
Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activity.
Leukemia & lymphoma 2005;46(10):1455-62.
2005: Arati V Rao; Gamal Akabani; David A Rizzieri
Radioimmunotherapy for Non-Hodgkin's Lymphoma.
Clinical medicine & research 2005;3(3):157-65.
2005: Ryan H Shanks; David A Rizzieri; James L Flowers; O Michael Colvin; David J Adams
Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4225-33.
2004: Yago Nieto; James J Vredenburgh; Elizabeth J Shpall; Scott I Bearman; Peter A McSweeney; Nelson Chao; David A Rizzieri; Cristina Gasparetto; Steven G Matthes; Anna E Barón; Roy B Jones
Phase II feasibility and pharmacokinetic study of concurrent administration of trastuzumab and high-dose chemotherapy in advanced HER2+ breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(21):7136-43.
2004: Jeffrey Talbot; Valerie K Ibom; David A Rizzieri; Robert Barrier; Donna Niedzwieki; Carlos M DeCastro; Joseph O Moore; Patrick Buckley; Rhonda Laney; Diane Stevenson; Heather Rumbaugh; Jon P Gockerman
Dose-intense cyclophosphamide and etoposide for patients with refractory or high-risk non-Hodgkin's lymphoma.
Clinical lymphoma 2004;5(2):116-22.
2004: Maura Gasparetto; Tracy Gentry; Said Sebti; Erica O'Bryan; Ramadevi Nimmanapalli; Michelle A Blaskovich; Kapil N Bhalla; David A Rizzieri; Perry Haaland; Jack Dunne; Clay Smith
Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening.
Journal of immunological methods 2004;292(1-2):59-71.
2004: Rajesh Bhagat; David A Rizzieri; James J Vredenburgh; Nelson J Chao; Rodney J Folz
Pulmonary sarcoidosis following stem cell transplantation: is it more than a chance occurrence?
Chest 2004;126(2):642-4.
2004: Nelson J Chao; Liang-Piu Koh; Gwynn D Long; Cristina Gasparetto; Mitchell Horwitz; Ashley Morris; Martha Lassiter; Keith M Sullivan; David A Rizzieri
Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(8):569-75.
2004: David A Rizzieri; Gamal Akabani; Michael R Zalutsky; R Edward Coleman; Scott D Metzler; James Bowsher; Bonnie Toaso; Elizabeth Anderson; Anand S Lagoo; Steve Clayton; Charles N Pegram; Joseph O Moore; Jon P Gockerman; Carlos M DeCastro; Cristina Gasparetto; Nelson J Chao; Darell D Bigner
Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma.
Blood 2004;104(3):642-8.
2004: Matthew J Snyder; Timothy T Stenzel; Patrick J Buckley; Anand S Lagoo; David A Rizzieri; Cristina Gasparetto; James J Vredenburgh; Nelson J Chao; Jerald Z Gong
Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation.
The American journal of surgical pathology 2004;28(6):794-800.
2004: David A Rizzieri; Gregory J Sand; Dean McGaughey; Joseph O Moore; Carlos M DeCastro; Nelson J Chao; James J Vredenburgh; Cristina Gasparetto; Gwynn D Long; Elizabeth Anderson; Traci Foster; Bonnie Toaso; David Adams; Donna Niedzwiecki; Jon P Gockerman
Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma.
Cancer 2004;100(11):2408-14.
2004: David A Rizzieri; Jeffrey L Johnson; Donna Niedzwiecki; Edward J Lee; James W Vardiman; Bayard L Powell; Maurice Barcos; Clara D Bloomfield; Charles Alan Schiffer; Bruce A Peterson; George P Canellos; Richard A Larson
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.
Cancer 2004;100(7):1438-48.
2003: Gwynn D Long; Mary Laughlin; Bella Madan; Joanne Kurtzberg; Cristina Gasparetto; Ashley Morris; David A Rizzieri; Clayton Smith; James J Vredenburgh; Edward C Halperin; Gloria Broadwater; Donna Niedzwiecki; Nelson J Chao
Unrelated umbilical cord blood transplantation in adult patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(12):772-80.
2003: Valerie K Ibom; Robert G Prosnitz; Jerald Z Gong; Joseph O Moore; Carlos M DeCastro; Leonard R Prosnitz; David A Rizzieri; Jon P Gockerman
Rituximab in lymphocyte predominance Hodgkin's disease: a case series.
Clinical lymphoma 2003;4(2):115-8.
2003: Jeffrey Talbot; David A Rizzieri; Carlos M DeCastro; Joseph O Moore; Patrick Buckley; Rhonda Laney; Diane Stevenson; Heather Brumbaugh; Jon P Gockerman
High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series.
American journal of hematology 2003;73(4):295-6.
2003: Jerald Z Gong; Timothy T Stenzel; Ellen R Bennett; Anand S Lagoo; Dunphy Cherie; Joseph O Moore; David A Rizzieri; James Tepperberg; Peter Papenhausen; Patrick J Buckley
Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases.
The American journal of surgical pathology 2003;27(6):818-27.
2003: David A Rizzieri; Jeffrey T Talbot; Gwynn D Long; James J Vredenburgh; Cristina Gasparetto; Clayton S Smith; Michael O Colvin; David Adams; Ashley Morris; Richard Dodge; Jennifer Loftis; Barbara Waters-Pick; Melissa Reese; Helen Carawan; Liang-Piu Koh; Nelson J Chao
4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(3):183-8.
2003: David A Rizzieri; Valerie K Ibom; Joseph O Moore; Carlos M DeCastro; Gary Rosner; David J Adams; Traci Foster; Nancy Payne; Maria Thompson; James J Vredenburgh; Cristina Gasparetto; Gwynn D Long; Nelson J Chao; Jon P Gockerman
Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):663-8.
2002: Michael A Morse; David A Rizzieri; Timothy T Stenzel; Amy C Hobeika; James J Vredenburgh; Nelson J Chao; Timothy M Clay; Paul J Mosca; H Kim Lyerly
Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants.
Journal of hematotherapy & stem cell research 2002;11(4):659-68.
2002: Adam J Bass; Jon P Gockerman; Eve Hammett; Carlos M DeCastro; David J Adams; Gary Rosner; Nancy Payne; Patti Davis; Traci Foster; Joseph O Moore; David A Rizzieri
Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(13):2995-3000.
2002: Steven L McCune; Jon P Gockerman; Joseph O Moore; Carlos M DeCastro; Adam J Bass; Nelson J Chao; Gwynn D Long; James J Vredenburgh; Cristina Gasparetto; David Adams; Nancy Payne; David A Rizzieri
Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia.
Leukemia & lymphoma 2002;43(5):1007-11.
2002: Cristina Gasparetto; Maura Gasparetto; Michael Morse; Barbara Alexander Rooney; James J Vredenburgh; Gwynn D Long; David A Rizzieri; Jennifer Loftis; Nelson J Chao; Clay Smith
Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSF.
Cytokine 2002;18(1):8-19.
2002: Adam J Bass; Jerald Gong; Ramona Nelson; David A Rizzieri
CD52 expression in mantle cell lymphoma.
Leukemia & lymphoma 2002;43(2):339-42.
2002: David A Rizzieri; Adam J Bass; Gary Rosner; Jon P Gockerman; Carlos M DeCastro; William P Petros; David J Adams; Mary J Laughlin; Patti Davis; Traci Foster; Robert Jacobson; Herbert I Hurwitz; Joseph O Moore
Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):674-9.
2002: Monic J Stuart; William P Peters; Gloria Broadwater; Atif Hussein; Maureen Ross; Lawrence Marks; Rodney J Folz; Gwynn D Long; David A Rizzieri; Nelson J Chao; James J Vredenburgh
High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(12):666-73.
2002: Nelson J Chao; Cong X Liu; Barbara Alexander Rooney; Benny J Chen; Gwynn D Long; James J Vredenburgh; Ashley Morris; Cristina Gasparetto; David A Rizzieri
Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(5):249-56.
2001: David A Rizzieri; Gwynn D Long; James J Vredenburgh; Cristina Gasparetto; Ashley Morris; Timothy T Stenzel; P Davis; Nelson J Chao
Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen.
Blood 2001;98(12):3486-8.
2001: S L McCune; Jon P Gockerman; David A Rizzieri
Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma.
JAMA : the journal of the American Medical Association 2001;286(10):1149-52.
2001: Mary J Laughlin; Juliet N Barker; B Bambach; Omer N Koc; David A Rizzieri; John E Wagner; Stanton L Gerson; Hillard M Lazarus; Mitchell S Cairo; Cladd E Stevens; Pablo Rubinstein; Joanne Kurtzberg
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.
The New England journal of medicine 2001;344(24):1815-22.
2001: Dean McGaughey; Daniel A Nikcevich; Gwynn D Long; James J Vredenburgh; David A Rizzieri; C A Smith; Gloria Broadwater; Jennifer Loftis; Carolyn McDonald; A K Morris; R F Folz; N F Chao
Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(5):274-8.
2000: Joel H Elconin; K B Roberts; David A Rizzieri; C Vermont; Robert W Clough; C Kim; Richard K Dodge; Leonard R Prosnitz
Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
International journal of radiation oncology, biology, physics 2000;48(4):1097-105.
1999: David A Rizzieri; James J Vredenburgh; Richard J Jones; Maureen Ross; Elizabeth J Shpall; Atif Hussein; Gloria Broadwater; Donald Berry; William P Petros; Colleen Gilbert; Mary Lou Affronti; David Coniglio; P Rubin; MA Elkordy; Gwynn D Long; Nelson J Chao; William P Peters
Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3064-74.
1998: Mary J Laughlin; David A Rizzieri; C A Smith; Joseph O Moore; S Lilly; Dean McGaughey; P Martin; Carmelita Carrier; Cladd E Stevens; Pablo Rubinstein; R Buckley; Joanne Kurtzberg
Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia.
Leukemia research 1998;22(3):215-9.
1998: Mary J Laughlin; Dean McGaughey; J R Crews; Nelson J Chao; David A Rizzieri; Maureen Ross; Jon P Gockerman; Constance Cirrincione; Donald Berry; L Mills; P Defusco; S LeGrand; William P Peters; James J Vredenburgh
Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1008-12.
1997: David A Rizzieri; Nelson J Chao
Treatment of non-Hodgkin's lymphoma with high-dose therapy and hematopoietic stem cell support.
Current opinion in oncology 1997;9(5):420-7.
1997: David A Rizzieri; J Liu; D Miralles; ST Traweek
Kaposi's-sarcoma-associated herpesvirus is detected in peripheral blood mononuclear cells of HIV-infected homosexuals more often than in heterosexuals.
The cancer journal from Scientific American 1997;3(3):153-6.
1997: David A Rizzieri; J Liu; ST Traweek; G D Miralles
Clearance of HHV-8 from peripheral blood mononuclear cells with a protease inhibitor.
Lancet 1997;349(9054):775-6.
1995: David A Rizzieri
Rhabdomyolysis after correction of hyponatremia due to psychogenic polydipsia.
Mayo Clinic proceedings. Mayo Clinic 1995;70(5):473-6.